Proc. roy. Soc. Med. Volume 62 May 1969 28 with which the scans are produced and the lifesize image that is obtained, which requires little experience in interpretation. Ultrasonic compound B scanning has two important advantages over the radioisotope technique: (1) There is no radiation, nor other known hazard of the method. (2) Not only is the placental edge visualized but also its relation to the presenting part and the cervix can be determined. This makes it possible to assess the degree of placenta prxevia more accurately and also to predict whether the head is likely to pass the placenta in minor degrees of placenta previa. The examination can readily be repeated if necessary. Furthermore, no special preparation of either patient or materials is required, and the examination takes 20-30 minutes to complete (compared to 30-40 minutes for a radioisotope scan). The disadvantages of this method lie partly in the skill required to perform the examination, but more especially in the considerable experience necessary to interpret the films correctly. Once these have been acquired, ultrasonic compound B scanning is the method of choice for placental localization.
Summary
(1) The results of 155 placental scans using 995Tc HSA are presented.
(2) In 75 patients a comparison between the radioisotope method and ultrasonic compound B scanning was made. There was disagreement in 10% of the patients, largely over whether or not the placenta encroached on the lower segment.
(3) The ultrasound technique offers two important advantages over the radioisotope method: there is no radiation hazard; the relations of the placenta, the presenting part and the lower uterine segment can be demonstrated. (4) It is concluded that ultrasonic compound B scanning is the method of choice for placental localization at the present time. Since the Sonar was installed in Aberdeen about a year ago we have made more and more use of it until some 200 scans are now done per month. We have found that it is a quick, safe, accurate method which positively identifies the placental site and its boundaries, irrespective of its position in the uterus. It is visible from an early stage in pregnancy and Sonar is more reliable than the Doptone or ultrasonic motion sensor. It is our first choice for placental localization in antepartum hemorrhage, unstable lie, and before amniocentesis.
We have found Sonar of great value in serial measurements in women with a bad obstetric historythis can be very reassuring for them.
We have used it in hydatidiform mole, in malpresentations, in multiple pregnancy, in assessment of maturity and rate of ftetal growth, and in gynmcological conditions. It is valuable not only as a routine method of determining abnormalities, but also in research, by comparing cephalometry and cestriol estimations to assess faetal and placental growth and function.
Sonar is being used to diagnose multiple pregnancies very early. The earliest time at which multiple pregnancy has been suspected was at seven weeks amenorrheea, because of two gestation rings that were present. The twin pregnancy was confirmed at the eighteenth week by the presence of two heads. This allows us to carry out various observations in the twin pregnancies from an early stage. We are measuring total body water, total hemoglobin mass and protein changes, with a view to establishing what can be considered to be a physiological response to a twin pregnancy.
It is of value in our researches into the syndrome of the small-for-dates baby. The pregnancy response changes which occur in the mother in pregnancies with poor faetal growth are being noted. They will be correlated with the weight of the baby at delivery and with its subsequent development.
Although at first we were rather sceptical and felt that Professor Donald's results might be somewhat biased, we are now thoroughly convinced of the great value of this equipment and would strongly support his claims for it.
